Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 375 results for "Victoza"

31 images for Victoza

Peoples Pharmacy, 2 days ago
Endocrinology Advisor, 2 weeks ago
Pharma Letter, 1 week ago
Pharma Letter, 2 months ago
DataMonitor HealthCare, 2 months ago
Pharma Letter, 2 months ago
BioPharma Dive, 2 months ago
FiercePharma, 3 months ago
Pharmafile, 4 months ago
FiercePharma, 5 months ago

Reading Novo's Insulin Portfolio to Find Clues about Its Growth

Novo Nordisk's (NVO) diabetes and obesity care portfolio consists of modern insulin, Victoza, human insulin, new generation insulin, and other diabetes and obesity
 Yahoo! Finance1 month ago

Novo Nordisk's Share Implosion Sends Shock Waves Through Denmark

View photosA box of Novo Nordisk A/S Victoza medication sits on a pharmacy shelf in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016. A Nov. 2015 forecast from health date firm IMS Health expects global sales of brand and generic prescription drugs, ...
 Yahoo! Finance1 month ago
Nasdaq

Novo Nordisk A/S 3Q 2016 -- Forecast

=== Sales: -NovoRapid/ 3rd Quarter -Total -Victoza -Levemir NovoLog AVERAGE 28,022 5,242 4,413 4,921 Prev. Year 26,792 4,680 ...
 Morningstar.com1 month ago Novo Nordisk shares plunge after drug giant slashes growth estimates  Local Tech Wire1 month ago NOVO NORDISK A/S : Bets on Riskier Insulin Research  4 Traders2 months ago Novo Nordisk Bets on Riskier Insulin Research  Pharma Focus Asia2 months ago
[x]  

Novo submits applications in U.S. and Europe to add CV benefit data to Victoza label

Novo Nordisk (NYSE: NVO ) submits a supplemental New Drug Application (sNDA) in the U.S. and a Type II Variation application in Europe seeking approval to add the cardiovascular (CV) outcomes data generated from the LEADER study in type 2 diabetics ...
 Seeking Alpha1 month ago Novo Nordisk files for EU and USA label for Victoza to include LEADER data  Pharma Letter1 month ago Novo Nordisk submits application to regulatory authorities to include LEADER data in Victoza(R) label  TD Ameritrade1 month ago NOVO NORDISK A/S : submits application to regulatory authorities to include LEADER data in Victoza® label  4 Traders1 month ago
[x]  
Peoples Pharmacy

Did Victoza for Diabetes Damage the Pancreas?

Type 2 diabetes has become an epidemic in the US and around the world. Doctors can choose froma number ofmedications to treat it. Each medicinehas its own side effect profile. Both patients and doctors may need to become familiar with possible ...
 Peoples Pharmacy2 days ago Type 2 Drug Linked to Weight Loss and Better Blood Glucose in Type 1 Diabetes  Diabetes Forecast1 month ago AskNadia: Do Opiates Affect People With Type 2 Diabetes  Diabetes Health Magazine1 week ago Liraglutide lessens risk of kidney disease progression in type 2 diabetes  PM 3602 weeks ago
TeleTrader.com

Novo Nordisk A/S : increased adjusted operating profit by 7% in local currencies in the first nine months of 2016

. Sales of Tresiba increased by 187% (184% in Danish kroner). Sales of Victoza increased by 13% (12% in Danish kroner). Sales of
 Singapore Star.com1 month ago Novo Nordisk 9-Month Profit Rises; Updates FY16 Outlook - Quick Facts  Quotenet.com1 month ago Novo Nordisk 9-Month Profit Rises  Finchannel.com1 month ago Novo Nordisk increased adjusted operating profit by 7% in local currencies in the first nine months of 2016  Biotechgate1 month ago
[x]  

Type 2 diabetes market to 2019 a shifting treatment algorithm and intensified competition expected to drive growth by 2019

Upcoming SlideShare Loading in … 5 1. Global Type 2 Diabetes Market has the Potential To Grow to Teach $38.8 Billion by 2019 "The Report Type 2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to ...
 SlideShare.net1 day ago Quid - Voice of Patient - Diabetes Type II  SlideShare.net2 months ago
Zacks.com

Novo Nordisk Files Regulatory Application for Semaglutide

Novo Nordisk A/S NVO announced that it has submitted a regulatory application for its glucagon-like peptide-1 (GLP-1) analogue, semaglutide (once-weekly), in both the U.S. and the EU for the treatment of adults with type II diabetes. A look at the ...
 Yahoo! Singapore2 days ago

Better Buy: MannKind Corp. vs. Novo Nordisk

More than 29 million Americans are currently diagnosed with diabetes. Treating this chronic disease is incredibly expensive. The American Diabetes Association estimates that the annual cost of caring for people with diabetes and prediabetes is $322 ...
 Motley Fool2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less